An interventional study of Surgical stabilization in Chronic Ankle Instability, sponsored by Gwendolyn Vuurberg. Completed at 3 sites in 3 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-10-03.
Sponsored by Gwendolyn Vuurberg · Not applicable, Interventional, and Treatment
Rationale: Lateral ankle ligament injuries may be a result of ankle sprains. In 10-30% of patients with lateral ankle ligament injuries, chronic lateral ankle instability may be present. If conservative treatment fails, instability is treated surgically. Anatomic repair (also known as the Bröstrom procedure) is the current golden standard for surgical treatment of chronic ankle instability. The Bröstrom started out as an open technique and is now also performed arthroscopically. Both approaches are considered standard care and provide good results. Which approach is best, has not yet been researched. In this study it is hypothesized arthroscopic repair provides better functional outcome compared to open repair during short term follow-up.
Objective: The main objective of this study is to compare the functional outcome after arthroscopic and open anatomic repair in patients with chronic lateral ankle instability, and secondly to assess ankle stability and ankle Range of Motion (ROM) after arthroscopic and open ligament repair.
Study design: A Non-Blinded Prospective Randomized Controlled Trial Study population: All patients willing to participate, from an age of 18 years old, with persisting ankle instability for at least 6 months, eligible for anatomic repair.
Intervention: Both groups of patients are surgically treated with anatomic repair of the anterior talofibular ligament (ATFL). One group is treated arthroscopically and the other by the open approach.
Main study parameters/endpoints: The primary outcome measure is functional outcome 6 months after surgery measured using the Foot and Ankle Outcome Score. The main study parameter is a difference of ≥10 2 points per FAOS subscale between both treatment groups (Minimal Important Change = 10 points; 2 per subscale).
This is the only study on the registry with Gwendolyn Vuurberg as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
These patients will receive open surgical stabilization of the ankle joint after failed conservative treatment with complaints for at least 6 months.
Procedure: Surgical stabilization
These patients will receive arthroscopic surgical stabilization of the ankle joint after failed conservative treatment with complaints for at least 6 months.
Procedure: Surgical stabilization
Surgical stabilization of the ankle joint, performed as an open or arthroscopic procedure.
Functional outcome
The primary outcome measures is a difference in pain and disability between both treatment groups as measured a Functional Ankle Outcome Score (FAOS) score change of ≥2 points per subscale measured at 6 months follow-up.
Time frame: 6 months
Functional outcome FAOS
For assessment disablement
Time frame: 3- and 6 months
Functional outcome Numeric Rating Scale (NRS) pain
For pain assessment
Time frame: 3- and 6 months
Functional outcome Cumberland Ankle Instability Tool (CAIT)
For instability assessment
Time frame: 3- and 6 months
Anterior Drawer Test (ADT)
The anterior drawer test is registered per mm (range 0-15mm) displacement and according to the manual anterior drawer test (M-ATT) categories (grade 0-3).
Time frame: Pre-operative, instraoperative, 3- and 6 months postoperative
Range of Motion (ROM)
ROM is registered in degrees of dorsi- and plantarflexion and is measured using a goniometer. Assessment is performed pre-operatively, and at 3- and 6-months postoperatively.
Time frame: Pre-operative, instraoperative, 3- and 6 months postoperative
Plan to share: No
This study is completed, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.